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Vitamin A deficiency - there’s more to it than meets the eye. 
Abstract 
Vitamin A deficiency (VAD) is the leading cause of preventable blindness in children worldwide 
and results in a well-recognised ocular phenotype. Herein we describe a patient presenting to 
the eye clinic with a retinal dystrophy and ocular colobomata. This combination of clinical signs, 
and consanguineous pedigree structure suggested a genetic basis for the disease, a hypothesis 
which was tested using whole genome sequencing. Bi-allelic mutations in RBP4 were identified 
(c.248+1G>A), consistent with a diagnosis of inherited vitamin A deficiency. We describe a 
constellation of clinical signs that should in future allow this diagnosis to be made using a less 
expensive and more rapid investigation: serum retinol level.  
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Vitamin A deficiency (VAD) is the leading cause of preventable blindness in children worldwide 
and results in a well-recognised ocular phenotype. Its primary cause is inadequate dietary 
intake and is a public health problem in over half of the world. In developed countries it results 
from either malabsorption or poor vitamin A metabolism due to liver disease. Herein we report a 
patient presenting to the eye clinic without typical features of VAD, and describe the 
investigations that were necessary to make a diagnosis.  
Case Report 
An Iranian lady from a consanguineous family presented with a history of left  
microphthalmia, bilateral iris and retinal colobomata and lifelong poor night vision.  
She described progressive visual loss resulting in only perception of light vision by the age of  
20 years. Her left microphthalmic eye had been enucleated in childhood and she  
now wears a prosthetic shell. When we examined her aged 25, the cornea and  
conjunctiva were normal and did not show the typical stigmata of VAD, including 
corneal clouding due to epithelial disease (xerophthalmia) or white, foamy 
conjunctival plaques (Bitot’s spots). In addition to the colobomata, the optic nerve 
was pale, and the retinal arterioles attenuated, suggesting widespread retinopathy  
that was confirmed by functional testing (Figure 1). The macula was atrophic and  
photoreceptor structure could not be identified using high-resolution imaging 
(Figure 2). She also had multiple sclerosis and malar skin pustules. In view of this  
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constellation of signs, and the prevalence of monogenic recessive disease in  
consanguineous families, a unifying molecular genetics diagnosis was sought. Whole genome 
sequencing was performed as part of a national collaborative project. [1] After bioinformatic 
processing, a previously unreported homozygous splice site mutation in RBP4 (NM006744) 
(c.248+1G>A) was identified, predicted to abolish the canonical splice donor site of intron 3. 
RBP4 encodes retinol binding protein 4, which is synthesised in the liver and responsible for 
transporting vitamin A to target organs. The patient’s serum vitamin A levels were therefore 
assayed and found to be undetectable, despite a healthy diet. 
Discussion 
Bi-allelic mutations in RBP4 have only been reported twice before and are thus a poorly 
recognised cause of disease [2,3]. Our patient and the published cases appear to share a 
distinctive phenotype comprising of a severe rod-cone dystrophy with ocular colobomata. Skin 
disease and additional autoimmune conditions may also coexist. [2,3] Together these features 
may facilitate early diagnosis and therapy in other patients.  
Vitamin A is an essential nutrient found mostly in animal products as retinyl esters, and in fruits 
and vegetables in the form of carotenoids (vitamin A precursors). Vitamin A and its derivatives 
regulate a range of essential biological processes both during embryogenesis, including closure 
of the optic fissure important for coloboma formation, and adulthood, producing the visual 
chromophore necessary for sight and maintaining epithelial cell health. Vitamin A also has an 
immunomodulatory role. It is likely therefore that the RBP4 dysfunction identified in our patient 
has wider non-ocular implications. Her overlooked skin condition may be responsive to topical 
retinoid therapy and low serum retinol levels may impact her MS and benefit from correction. [4] 
One quarter of our Vitamin A is transported unbound to RBP4, and consequently has a short 
half-life due to renal excretion. Small regular meals rich in vitamin A would provide some 
compensation for this. There are also implications for family planning as foetal development 
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would be compromised, also now modifiable in light of the genetic diagnosis. 
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Figure  Legends 
Figure 1. Colour fundus photograph of the right retina showing the posterior component of a 
large inferior chorioretinal coloboma, central retinal atrophy, pale and atrophic optic nerve and 
attenuated retinal arterioles.  
Figure 2. (A) Near infrared en-face image of the patient’s retina showing optical coherence 
tomography (OCT) line scan position through the macula, (B) Macular OCT scan with absence 
of lines in the outer retina localising damage to the photoreceptor layer (C) normal macular OCT 
scan and (D) histological section (from a donor eye) for comparison.  
